Altimmune, Inc.
ALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326190
In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Altimmune, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 119 | 1 | 102 | −16 |
| Shares | 32.9M | 791.6K | 32.5M | +379.9K (+1.2%) |
| Value | $375.3M | $8.95M | $295.8M | −$70.6M (−19.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Altimmune, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 576,422 | $5.28M | 0.01% |
| Two Sigma Advisers, LP | 557,200 | $5.10M | 0.01% |
| PDT Partners, LLC | 118,876 | $1.09M | 0.08% |
| Cubist Systematic Strategies, LLC | 91,391 | $837.0K | 0.01% |
| Dimensional Fund Advisors LP | 78,470 | $719.0K | 0.00% |
| Walleye Capital LLC | 72,304 | $662.0K | 0.02% |
| Renaissance Technologies LLC | 66,800 | $612.0K | 0.00% |
| Walleye Trading LLC | 49,083 | $450.0K | 0.01% |
| Gsa Capital Partners LLP | 48,997 | $449.0K | 0.06% |
| Jump Financial, LLC | 45,400 | $416.0K | 0.03% |
| NinePointTwo Capital | 37,168 | $340.0K | 0.11% |
| Russell Investments Group, Ltd. | 27,000 | $247.0K | 0.00% |
| XTX Topco Ltd | 14,767 | $135.0K | 0.08% |
| E Fund Management Co., Ltd. | 11,936 | $109.0K | 0.00% |
| Point72 Hong Kong Ltd | 5,396 | $49.0K | 0.00% |
| CWM, LLC | 775 | $7.00K | 0.00% |
| Carroll Investors, Inc | 272 | $2.00K | 0.00% |
| Cornerstone Advisory, LLC | 32 | $0 | 0.00% |
| BCR Wealth Strategies, LLC | 4 | $0 | 0.00% |
Sold out (35)
Institutions that held Altimmune, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (1)
Institutions that held Altimmune, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 791,606 | $8.95M |